Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer
Author:
Affiliation:
1. The University of Texas at Austin, College of Pharmacy, Pharmaceutics Division, Austin, Texas 78712, United States
2. University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina 27599, United States
Funder
National Cancer Institute
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.5b00987
Reference43 articles.
1. Inhibition of breast cancer cell migration by activation of cAMP signaling
2. Intrinsic cancer subtypes-next steps into personalized medicine
3. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
4. Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
5. What common biomarkers characterize a triple-negative profile in breast cancer?
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals;Advanced Materials;2023-12-31
2. Targeted therapy of breast tumor by PLGA-based nanostructures: The versatile function in doxorubicin delivery;Environmental Research;2023-09
3. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer;Recent Patents on Anti-Cancer Drug Discovery;2023-08
4. Antitumor therapy for breast cancer: Focus on tumor‐associated macrophages and nanosized drug delivery systems;Cancer Medicine;2023-02-16
5. Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting;Cancer Medicine;2023-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3